一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

返回ChemicalBook首頁(yè)>CAS數(shù)據(jù)庫(kù)列表>1222102-51-3

1222102-51-3

中文名稱 Evogliptin Tartrate
英文名稱 Evogliptin Tartrate
CAS 1222102-51-3
分子式 C19H26F3N3O3 · (C4H6O6)
分子量 551.52
MOL 文件 1222102-51-3.mol
更新日期 2026/06/02 13:23:01
1222102-51-3 結(jié)構(gòu)式 1222102-51-3 結(jié)構(gòu)式

基本信息

中文別名
化合物 T11248
英文別名
DA-1229 tartrate
Evogliptin Tartrate

物理化學(xué)性質(zhì)

儲(chǔ)存條件-20°C儲(chǔ)存
溶解度DMSO: 100 mg/mL (181.32 mM)
形態(tài)Solid
顏色White to off-white
Evogliptin Tartrate價(jià)格(試劑級(jí))
報(bào)價(jià)日期產(chǎn)品編號(hào)產(chǎn)品名稱CAS號(hào)包裝價(jià)格
2025/12/22HY-117985BEvogliptin tartrate1222102-51-31 mg1000元
2025/12/22HY-117985BEvogliptin Tartrate
Evogliptin tartrate
1222102-51-35mg2800元
2025/12/22HY-117985BEvogliptin Tartrate
Evogliptin tartrate
1222102-51-310mM * 1mLin DMSO3397元

常見問題列表

生物活性
Evogliptin tartrate 是一種高效、口服有效、選擇性的 DPP-4 抑制劑,具有抗糖尿病活性。Evogliptin tartrate 可用于靶向動(dòng)脈炎癥和動(dòng)脈粥樣硬化的研究。
靶點(diǎn)

DPP-4

體外研究

Evogliptin tartrate significantly inhibits the TNF-α-mediated induction of ICAM-1 and VCAM-1 expression in a concentration-dependent manner (IC 50 = 0.30 and 0.25 μM, respectively).
Evogliptin tartrate inhibits the TNF-α-mediated transcriptional activation of ICAM-1 and VCAM-1.
Evogliptin tartrate inhibits inflammatory responses via suppression of adhesion molecules induced by TNF-α. And TNF-α-mediated activation of NF-κB is ameliorated by evogliptin via the interaction of NF-κB with SIRT1.

Cell Viability Assay

Cell Line: Endothelial cells
Concentration: 0.1 μM, 0.3 μM, 1 μM, 3 μM
Incubation Time: 12 hours
Result: Inhibits TNF-α-mediated (10 ng/ml) expression of adhesion molecules.
體內(nèi)研究

Evogliptin tartrate (37.5-150 mg/kg; p.o.; daily; for 12 weeks) reduces the high-fat diet-induced atherosclerotic plaque area in the ApoE ?/? mouse model.
Evogliptin tartrate inhibits the formation of atherosclerotic lesions by reducing vasoinflammation and increases plaque stability.

Animal Model: ApoE ?/? mice
Dosage: 37.5 mg/kg, 75 mg/kg, 150 mg/kg
Administration: Oral administration; daily; for 12 weeks
Result: Inhibit the development of atherosclerosis.
"1222102-51-3" 相關(guān)產(chǎn)品信息
仙游县| 从化市| 澜沧| 华宁县| 广宗县| 赤水市| 莲花县| 密云县| 湖南省| 淮北市| 甘南县| 永康市| 伊吾县| 孟村| 牙克石市| 宜昌市| 广东省| 桂东县| 枣庄市| 绥中县| 饶阳县| 黄龙县| 华坪县| 南乐县| 克山县| 屏山县| 吴川市| 敦化市| 三都| 永城市| 太原市| 库尔勒市| 盐亭县| 云霄县| 图木舒克市| 临西县| 固始县| 德阳市| 昌平区| SHOW| 宝山区|